Clearance Summary
MICROLET NEXT lancing device, MICROLET Lancet received FDA 510(k) clearance under submission number K220633, sponsored by Ascensia Diabetes Care U.S., Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2022-06-03.
- Submission: K220633
- Applicant / Sponsor: Ascensia Diabetes Care U.S., Inc.
- Clearance pathway: Traditional
- Review panel: General, Plastic Surgery
- Device class: Class II
- Regulation citation: 21 CFR 878.4850
- Decision date: 2022-06-03
Classification & Regulation
This clearance is catalogued under FDA product code QRL and 21 CFR 878.4850, within the General, Plastic Surgery review panel as a Class II device.